McGrath M E, Erpel T, Bystroff C, Fletterick R J
Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448.
EMBO J. 1994 Apr 1;13(7):1502-7. doi: 10.1002/j.1460-2075.1994.tb06411.x.
The 2.4 A crystal structure (R = 0.180) of the serine protease inhibitor ecotin was determined in a complex with trypsin. Ecotin's dimer structure provides a second discrete and distal binding site for trypsin and, as shown by modelling experiments, other serine proteases. The second site is approximately 45 A from the reactive/active site of the complex and features 13 hydrogen bonds, including six that involve carbonyl oxygen atoms and four bridged by water molecules. Contacts ecotin makes with trypsin's active site are similar to, though more extensive than, those found between trypsin and basic pancreatic trypsin inhibitor. The side chain of ecotin Met84 is found in the substrate binding pocket of trypsin where it makes few contacts, but also does not disrupt the solvent structure or cause misalignment of the scissile bond. This first case of protein dimerization being used to augment binding energy and allow chelation of a target protein provides a new model for protein-protein interactions and for protease inhibition.
测定了丝氨酸蛋白酶抑制剂依可丁与胰蛋白酶复合物的2.4埃晶体结构(R = 0.180)。依可丁的二聚体结构为胰蛋白酶以及建模实验所示的其他丝氨酸蛋白酶提供了第二个离散且较远的结合位点。第二个位点距离复合物的反应/活性位点约45埃,具有13个氢键,其中包括6个涉及羰基氧原子的氢键和4个由水分子桥连的氢键。依可丁与胰蛋白酶活性位点的接触与胰蛋白酶和碱性胰腺胰蛋白酶抑制剂之间的接触相似,但更为广泛。依可丁Met84的侧链位于胰蛋白酶的底物结合口袋中,在此处它几乎没有接触,但也不会破坏溶剂结构或导致可裂解键的错位。这种利用蛋白质二聚化增强结合能并实现靶蛋白螯合的首例情况为蛋白质-蛋白质相互作用和蛋白酶抑制提供了新模型。